• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-安全性研究 • 上一篇    下一篇

1例华法林相关遗传因素所致INR升高的

张阳   

  1. 昆明市第一人民医院
  • 收稿日期:2016-09-19 修回日期:2017-04-14 出版日期:2017-04-25 发布日期:2017-04-25

A Case Report about Genetic Factors of WarfarinLeading to the Rise of INR

  1. First hospital of Kunming
  • Received:2016-09-19 Revised:2017-04-14 Online:2017-04-25 Published:2017-04-25

摘要: [摘 要]随着个体化医疗和精准医疗的发展,华法林给药剂量大多已采取个体化剂量公式来计算,其中就包括患者的基因型,以及年龄、体重、身高。为了避免因服用华法林过量而导致的凝血功能指标异常和出血不良反应,建议需服用华法林患者在用药前进行基因检测,并加强对患者的用药教育,严格控制凝血功能指标,防治潜在的出血风险,提高患者的抗凝治疗。

Abstract: The dosage of warfarin was confirmed by individual software which considered genotype, age, weight, and height with the development of individualized medicine and Precision Medicine. In order to avoid the abnormal coagulative function index and bleeding adverse reactions caused by excessive warfarin,genetic test before oral warfarin should be considered. medication education for patients,vital control of coagulative function index, and prevention of potential risk of bleeding should be taken into account to improve the patient''s anticoagulant therapy.